Home | Welcome to Contract Pharma   
Last Updated Sunday, May 19 2013
Print

Financial Report: Covance 1Q



Published April 30, 2009
Related Searches: Financial Reports
Covance 1Q

1Q Revenues: $468.4 million (+8%)

1Q Earnings: $40.3 million (-18%)

Comments: Early development revenues were $192.5 million (-5%). Late-stage development revenues were up 18% to $248.7 million. Backlog at March 31, 2009 was up 54% to $4.4 billion. Adjusted net orders (orders adjusted for dedicated capacity contracts) were $589 million in the quarter.



blog comments powered by Disqus
Receive free Contract Pharma Direct emails
Sign up now to receive the weekly newsletter, and more!

Enter your email address:

Follow Contract Pharma On